British Scientists Use Mould to Create Biological Robot

Slime mould usually gets a bad rap but this microscopic fungus is a star player in the scientific world. British researchers have announced they will use slime mould to design the first ever biological robot: a development that will impact the field of computational robotics.

The scientists from the University of the West of England (UWE) Bristol presented 'plasmobot', an amorphous, non-silicon biological robot. The key ingredient in their design was plasmodium, which is the vegetative stage of the slime mould Physarum polycephalum that is commonly found in forests and gardens in the UK.

Project leader Andy Adamatzky of the Department of Computer Science at UWE Bristol said the team's previous work proved how mould is capable of having computational skills. "Most people's idea of a computer is a piece of hardware with software designed to carry out specific tasks. This mould, or plasmodium, is a naturally occurring substance with its own embedded intelligence," he explained.

"It propagates and searches for sources of nutrients and when it finds such sources it branches out in a series of veins of protoplasm," Professor Adamatzky added. "The plasmodium is capable of solving complex computational tasks, such as the shortest path between points and other logical calculations."

The team succeeded in making the mould transport objects in previous experiments, he said. "By feeding it oat flakes, it grows tubes which oscillate and make it move in a certain direction carrying objects with it," Professor Adamatzy said. "We can also use light or chemical stimuli to make it grow in a certain direction."

The plasmobot could sense and span objects, and transport small objects along pre-programmed directions, according to the UWE researcher. "The robots will have parallel inputs and outputs, a network of sensors and the number of crunching power of super computers," he said. "The plasmobot will be controlled by spatial gradients of light, electro-magnetic fields and the characteristics of the substrate on which it is placed."

Professor Adamatzy pointed out that the plasmobot will be a "fully controllable and programmable amorphous intelligent robot with an embedded massively parallel computer."

This latest development will clear the path for the team to conduct further experiments on how mould can be controlled and used for its computational abilities.

"We are at the very early stages of our understanding of how the potential of the plasmodium can be applied, but in years to come we may be able to use the ability of the mould for example to deliver a small quantity of a chemical substance to a target, using light to help to propel it, or the movement could be used to help assemble micro-components of machines," Professor Adamatzky remarked.

The next development would be to harness the power of plasmodia within the human body. The delivery of drugs to certain parts of the body is an example.

"It might also be possible for thousands of tiny computers made of plasmodia to live on our skin and carry out routine tasks freeing up our brain for other things," Professor Adamatzy surmised. "Many scientists see this as a potential development of amorphous computing, but it purely theoretical at the moment."

For further information, please visit:
University of the West of England, http://www.uwe.ac.uk

Copyright ©European Communities, 2009
Neither the Office for Official Publications of the European Communities, nor any person acting on its behalf, is responsible for the use, which might be made of the attached information. The attached information is drawn from the Community R&D Information Service (CORDIS). The CORDIS services are carried on the CORDIS Host in Luxembourg - http://cordis.europa.eu. Access to CORDIS is currently available free-of-charge.

Most Popular Now

Philips Foundation 2024 Annual Report: E…

Marking its tenth anniversary, Philips Foundation released its 2024 Annual Report, highlighting a year in which the Philips Foundation helped provide access to quality healthcare for 46.5 million people around...

New AI Transforms Radiology with Speed, …

A first-of-its-kind generative AI system, developed in-house at Northwestern Medicine, is revolutionizing radiology - boosting productivity, identifying life-threatening conditions in milliseconds and offering a breakthrough solution to the global radiologist...

Scientists Argue for More FDA Oversight …

An agile, transparent, and ethics-driven oversight system is needed for the U.S. Food and Drug Administration (FDA) to balance innovation with patient safety when it comes to artificial intelligence-driven medical...

New Research Finds Specific Learning Str…

If data used to train artificial intelligence models for medical applications, such as hospitals across the Greater Toronto Area, differs from the real-world data, it could lead to patient harm...

Giving Doctors an AI-Powered Head Start …

Detection of melanoma and a range of other skin diseases will be faster and more accurate with a new artificial intelligence (AI) powered tool that analyses multiple imaging types simultaneously...

AI Agents for Oncology

Clinical decision-making in oncology is challenging and requires the analysis of various data types - from medical imaging and genetic information to patient records and treatment guidelines. To effectively support...

Patients say "Yes..ish" to the…

As artificial intelligence (AI) continues to be integrated in healthcare, a new multinational study involving Aarhus University sheds light on how dental patients really feel about its growing role in...

Brains vs. Bytes: Study Compares Diagnos…

A University of Maine study compared how well artificial intelligence (AI) models and human clinicians handled complex or sensitive medical cases. The study published in the Journal of Health Organization...

'AI Scientist' Suggests Combin…

An 'AI scientist', working in collaboration with human scientists, has found that combinations of cheap and safe drugs - used to treat conditions such as high cholesterol and alcohol dependence...

Start-ups in the Spotlight at MEDICA 202…

17 - 20 November 2025, Düsseldorf, Germany. MEDICA, the leading international trade fair and platform for healthcare innovations, will once again confirm its position as the world's number one hotspot for...